10
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Expansion of large granular lymphocytes following Pseudomonas infection in a patient with adult-onset Still's disease

, , &
Pages 101-104 | Received 21 Nov 2005, Accepted 14 Feb 2006, Published online: 02 Jan 2014

References

  • Bowman SJ, Geddes GC, Corrigan V, Panayi GS, Lanchbury JS. Large granular lymphocyte expansions in Felty's syndrome have an unusual phenotype of activated CD45FtA+ cells. Br J Ftheumatol 1996;35: 1252–5.
  • Ozaki M, Kawabe Y, Nakamura H, Migita K, Kawakami A, Tsukazaki K, et al. Elevated serum cytokine levels in a rheumatoid arthritis patient with large granular lymphocyte syndrome. Ftheu-matology 2001;40:592–3.
  • Loughran TP Jr, Starkebaum G. Large granular lymphocyte leuke-mia. Report of 38 cases and review of the literature. Medicine (Baltimore) 1987;66(5):397–405.
  • Shvidel L, Duksin C, Tzimanis A, Shtalrid M, Klepfish A, Sigler E, et al. Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders. Hematol J 2002;3:32–7.
  • Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Ftheumatol 1992;19:424–30.
  • Bywaters EGL. Still's disease in the adult. Ann Rheum Dis 1971; 30:121–32.
  • Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM. Macrophage activation syndrome and rheumatic disease in child-hood: a report of four new cases. Clin Exp Ftheumatol 1993;11:451–6.
  • Arai Y, Handa T, Mitani K. Adult-onset Still disease presenting with disseminated intravascular coagulation (in Japanese). Jpn J Clin Hematol 2004;45:316-8.16.
  • Muta T, Yamano Y. Fulminant hemophagocytic syndrome with a high interferon y level diagnosed as macrophage activation syn-drome. Int J Hematol 2004;79:484–7.
  • Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK, Kim SS, et al. Serum 17. cytokine profiles in patients with adult onset Still's disease. J Ftheumatol 2003;30:2422–7.
  • Madson KL, Moore TL, Lawrence JM 3rd, Osborn TG. Cytokine levels in serum and synovial fluid of patients with juvenile rheuma- 18. toid arthritis. J Ftheumatol 1994;21:2359–63.
  • Lepore L, Pennesi M, Saletta S, Perticarari S, Presani G, Prodan M. Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. 19. Clin Exp Ftheumatol 1994;12:561–5.
  • Mangge H, Kenzian H, Gallistl S, Neuwirth G, Liebmann P, Kaulfersch W, et al. Serum cytokines in juvenile rheumatoid arthri-tis. Correlation with conventional inflammation parameters and 20. clinical subtypes. Arthritis Rheum 1995;38:211–20.
  • Rooney M, Varsani H, Martin K, Lombard PR, Dayer JM, Woo P. Tumour necrosis factor alpha and its soluble receptors in juvenile 21. chronic arthritis. Rheumatology 2000;39:432–8.
  • Shibolet 0, Iian Y, Gillis S, Hubert A, Shouval D, Safadi R. Lamivudine therapy for prevention of immunosuppressive- induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood 2002;100:391-6. Michelini-Norris MB, Blanchard DK, Friedman H, Djeu JY. Involvement of HLA-DR+ large granular lymphocytes in the induction of tumor necrosis factor by Mycobacterium avium-intracellulare complex. J Leukoc Biol 1991;50:529-38. Blanchard DK, Michelini-Norris MB, Pearson CA, Freitag CS, Djeu JY. Mycobacterium avium-intracellulare induces interleukin-6 from human monocytes and large granular lymphocytes. Blood 1991;77:2218-24. Blanchard DK, McMillen S, Hoffman SL, Djeu JY. Mycobacterial induction of activated killer cells: possible role of tyrosine kinase activity in interleukin-2 receptor alpha expression. Infect Immun 1992;60:2843-9. Tarkkanen J, Kosunen TU, Saksela E. Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect Immun 1993; 61:3012-6. Pinola M, Saksela E. Adhesion molecules involved in the interac-tion of LGUNK cells and human endothelial cells stimulated with Salmonella bacteria. Scand J Immunol 1992;36:671-9. Tarkkanen J, Saksela E. Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase. Infect Immun 1991;59: 2767–73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.